Eulerpool Terminal
The edge that pays for itself.
Current Traws Pharma forecasts and price targets in August 2026
Ø Analyst Price Targets
8.16 USD
+1,411.11 %
Median
8.16 USD
+1,411.11 %
Max
8.40 USD
Min
8.08 USD
Last Price
0.54 USD
Buy
6
Hold
1
Sell
0
The average target price for Traws Pharma is 8.16 USD. (+1,411.11 % above the current price)
The median price target of Traws Pharma is 8.16 USD.
Stock analysts from many renowned investment banks are closely examining the Traws Pharma stock. They conclude their professional Traws Pharma stock analyses with a clear recommendation for the Traws Pharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 6 | 1 | 0 | 8.16 USD |
| 2026-01-01 | 6 | 1 | 0 | 8.16 USD |
| 2025-04-01 | 6 | 1 | 0 | — |
| 2025-03-01 | 6 | 1 | 0 | — |
| 2025-02-01 | 6 | 1 | 0 | 153.00 USD |
| 2025-01-01 | 6 | 1 | 0 | 153.00 USD |
Traws Pharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Traws Pharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 2.00 M USD | — | — |
| 2027e | 26.00 M USD | -10.00 M USD | -6.44 USD |
| 2028e | 58.00 M USD | — | — |